These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1922173)

  • 21. Botulinum A toxin treatment in spasmodic torticollis: report of 56 patients.
    Poungvarin N; Viriyavejakul A
    J Med Assoc Thai; 1994 Sep; 77(9):464-70. PubMed ID: 7706965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor.
    Jankovic J; Schwartz K; Clemence W; Aswad A; Mordaunt J
    Mov Disord; 1996 May; 11(3):250-6. PubMed ID: 8723140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
    Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
    Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of EMG interference pattern analysis in botulinum toxin treatment of torticollis: a randomised, controlled and blinded study.
    Werdelin L; Dalager T; Fuglsang-Frederiksen A; Regeur L; Karlsborg M; Korbo L; Munck O; Winge K
    Clin Neurophysiol; 2011 Nov; 122(11):2305-9. PubMed ID: 21636319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of resistance to botulinum toxin type A in patients with torticollis.
    Greene P; Fahn S; Diamond B
    Mov Disord; 1994 Mar; 9(2):213-7. PubMed ID: 8196686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Injection of botulinum toxin as a new treatment of torticollis].
    Aquilonius SM; Cesarini KG; Stålberg E
    Lakartidningen; 1990 Dec; 87(51-52):4408-10. PubMed ID: 2177127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patients].
    Novis SA; De Mattos JP; De Rosso AL
    Arq Neuropsiquiatr; 1995 Sep; 53(3-A):403-10. PubMed ID: 8540813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
    Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study.
    Freund BJ; Schwartz M
    J Rheumatol; 2000 Feb; 27(2):481-4. PubMed ID: 10685817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
    Sahai A; Dowson C; Khan MS; Dasgupta P
    BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of focal dystonia with botulinum toxin].
    Nagamine T; Kaji R; Hamano T; Kimura J
    Rinsho Shinkeigaku; 1991 Jan; 31(1):32-7. PubMed ID: 2044303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
    Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
    J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study.
    Girlanda P; Quartarone A; Sinicropi S; Nicolosi C; Messina C
    Mov Disord; 1996 Jan; 11(1):27-31. PubMed ID: 8771064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
    Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
    Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
    Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin A in the prophylactic treatment of migraine--a randomized, double-blind, placebo-controlled study.
    Evers S; Vollmer-Haase J; Schwaag S; Rahmann A; Husstedt IW; Frese A
    Cephalalgia; 2004 Oct; 24(10):838-43. PubMed ID: 15377314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of spasmodic torticollis by local injections of botulinum toxin].
    Jedynak CP; de Saint Victor JF
    Rev Neurol (Paris); 1990; 146(6-7):440-3. PubMed ID: 2399409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accurate targeting of botulinum toxin injections: how to and why.
    Lim EC; Quek AM; Seet RC
    Parkinsonism Relat Disord; 2011 Nov; 17 Suppl 1():S34-9. PubMed ID: 21999895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.